Jentadueto™ (linagliptin/metformin HCl) tablets in the Management and Treatment of Adults With Type 2 Diabetes Mellitus

被引:0
作者
Schwartz, Stanley [1 ]
机构
[1] Main Line Hlth Syst, Ardmore, PA USA
关键词
FIXED-DOSE COMBINATION; AMERICAN ASSOCIATION; DOUBLE-BLIND; METFORMIN; THERAPY; STATEMENT; ADHERENCE; SECRETION; ALGORITHM; EFFICACY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A1 / A14
页数:14
相关论文
共 22 条
[1]  
[Anonymous], 2011, National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States
[2]   Rosiglitazone/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: A 24-week, multicenter, randomized, double-blind, parallel-group study [J].
Bailey, CJ ;
Bagdonas, A ;
Rubes, J ;
McMorn, SO ;
Donaldson, J ;
Biswas, N ;
Stewart, MW .
CLINICAL THERAPEUTICS, 2005, 27 (10) :1548-1561
[3]   Response to comment on: American Diabetes Association. Standards of medical care in diabetes-2011 (vol 34, pg e54, 2011) [J].
Wysham, C. H. ;
Kirkman, M. S. .
DIABETES CARE, 2011, 34 (08) :1887-1887
[4]  
Boehringer Ingelheim Pharmaceuticals Inc., 2011, TRADJ LIN PRESC INF
[5]  
BoehringerIngelheim Pharmaceuticals Inc., 2011, JENT LIN METF HCI TA
[6]   Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence [J].
Boyle, James P. ;
Thompson, Theodore J. ;
Gregg, Edward W. ;
Barker, Lawrence E. ;
Williamson, David F. .
POPULATION HEALTH METRICS, 2010, 8
[7]   From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus [J].
DeFronzo, Ralph A. .
DIABETES, 2009, 58 (04) :773-795
[8]   Enhancing incretin action for the treatment of type 2 diabetes [J].
Drucker, DJ .
DIABETES CARE, 2003, 26 (10) :2929-2940
[9]  
Duckworth William, 2003, J Manag Care Pharm, V9, P256
[10]   PLASMA INSULIN RESPONSE TO ORAL + INTRAVENOUS GLUCOSE ADMINISTRATION [J].
ELRICK, H ;
HLAD, CJ ;
ARAI, Y ;
STIMMLER, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1964, 24 (10) :1076-+